[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 174.129.114.211. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Citations 0
Correction
April 9, 2007

Error in Figure in: Outpatient Hypertension Treatment, Treatment Intensification, and Control in Western Europe and the United States

Arch Intern Med. 2007;167(7):648. doi:10.1001/archinte.167.7.648

In the Original Investigation by Wang et al titled “Outpatient Hypertension Treatment, Treatment Intensification, and Control in Western Europe and the United States,” published in the January 22 issue of the ARCHIVES (2007;167:141-147), an error occurred in Figure 1 on page 144. In that figure, the order of countries in the key, to coordinate with the shading of the bars from darkest to lightest, should have appeared as follows: France (n = 3009), Germany (n = 3178), Italy (n = 3316), Spain (n = 3704), United Kingdom (n = 2809), and United States (n = 3750). The corrected figure is reproduced here with its legend.

Figure 1.
Cross-national differences in the use of 7 antihypertensive drug classes and combination drug therapy among treated hypertensive patients. ACE indicates angiotensin-converting enzyme; ARB, angiotensin II receptor blocker; and CCB, calcium channel blocker.

Cross-national differences in the use of 7 antihypertensive drug classes and combination drug therapy among treated hypertensive patients. ACE indicates angiotensin-converting enzyme; ARB, angiotensin II receptor blocker; and CCB, calcium channel blocker.

×